Following the administration of α-solanine (6 μg/g for 2 weeks) in xenograft model, tumor volume and weight were decreased by 61% and 43% (p<0.05) respectively, showing decreased MMP-2/9, PCNA and VEGF expression. Here, MMP2 is linked to neoplasm.